Calls to expand access to Covid antivirals in Australia splits experts and doctors

• Doctors and other medical experts differ in ideas about calls for eligibility expansion of Covid antivirals Lagevrio and Paxlovid.
• Federal Health Minister Mark Butler encourages doctors and patients to consider both drugs since they effectively reduce the symptoms of the virus.
• Professor Mike Toole notes the necessity of more data about the effects of the antivirals before its eligibility expansion.
• Dr. Bruce Willett points out the significance of enhancing community awareness about the drugs while ensuring their access.